Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
1.100
0.00 (0.00%)
Sep 20, 2024, 4:00 PM EDT - Market closed
Rallybio Market Cap
Rallybio has a market cap or net worth of $45.64 million as of September 20, 2024. Its market cap has decreased by -77.77% in one year.
Market Cap
45.64M
Enterprise Value
-42.69M
1-Year Change
-77.77%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $45.64M, a decrease of -88.75%. That is a compound annual growth rate of -50.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2024 | 45.60M | -49.50% |
| Dec 29, 2023 | 90.30M | -57.10% |
| Dec 30, 2022 | 210.50M | -31.32% |
| Dec 31, 2021 | 306.50M | -24.43% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reviva Pharmaceuticals Holdings | 46.99M |
| ProPhase Labs | 46.74M |
| Inotiv | 46.55M |
| Aadi Bioscience | 45.78M |
| LAVA Therapeutics | 45.76M |
| CareCloud | 45.40M |
| Fortress Biotech | 45.17M |
| Singular Genomics Systems | 45.07M |